Strides Pharma Shares Gain After Acquiring 4 ANDAs for the US Market
Strides Pharma Science shares saw a notable increase in early trading on April 30, following the announcement of its US-based subsidiary's acquisition of four ANDAs from Nostrum Laboratories Inc. These acquisitions are poised to strengthen Strides' position in the US market.Market PerformanceCurr...
Easy & quick